Development of Novel Measures for Alzheimer's Disease Prevention Trials
Public ClinicalTrials.gov record NCT03900273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Development of Novel Measures of Cognition and Function for Alzheimer's Disease Prevention Trials
Study identification
- NCT ID
- NCT03900273
- Recruitment status
- Suspended
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- New York State Psychiatric Institute
- Other
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Interventions
- No Practice Effects (NPE) cognitive battery, and Miami Computerized Functional Assessment Scale (CFAS) Other
- Preclinical Alzheimer's Cognitive Composite (PACC), Alzheimer's Disease Assessment Scale-Cognitive Scale (ADAS-Cog), and Functional Assessment Questionnaire (FAQ) Other
Other
Eligibility (public fields only)
- Age range
- 60 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2019
- Primary completion
- Aug 30, 2025
- Completion
- Aug 30, 2026
- Last update posted
- Oct 30, 2025
2019 – 2026
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | — |
| University of Miami | Miami | Florida | 33136 | — |
| The Feinstein Institute for Medical Research | Manhasset | New York | 11030 | — |
| New York State Psychiatric Institute | New York | New York | 11032 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03900273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 30, 2025 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03900273 live on ClinicalTrials.gov.